Novel advances in drug delivery to brain cancer (Q36200166)

12 August 2017

1 reference

title

Novel advances in drug delivery to brain cancer (English)

1 reference

12 August 2017

1 reference

1 reference

Maciej S Lesniak

1

1 reference

12 August 2017

1 August 2005

1 reference

Technology in Cancer Research and Treatment

12 August 2017

12

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

12 August 2017

4

1 reference

12 August 2017

4

1 reference

12 August 2017

417-428

1 reference

12 August 2017

Brain tumors. Part 2.

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

21 January 2018

Brain tumors. Part 1.

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Solid stress generated by spheroid growth estimated using a linear poroelasticity model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

High concentration of Daunorubicin and Daunorubicinol in human malignant astrocytomas after systemic administration of liposomal Daunorubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

High intratumoural accumulation of stealth liposomal doxorubicin (Caelyx) in glioblastomas and in metastatic brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Long-term stabilization in patients with malignant glioma after treatment with liposomal doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Liposomal daunorubicin (DaunoXome) in children with recurrent or progressive brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Nanoparticle technology for delivery of drugs across the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Advances in osmotic opening of the blood-brain barrier to enhance CNS chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Etoposide with or without mannitol for the treatment of recurrent or primarily unresponsive brain tumors: a Children's Cancer Group Study, CCG-9881.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Locally delivered chemotherapy and repeated surgery can improve survival in glioblastoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Bleomycin and brain tumors. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

A phase I trial of continuously infused intratumoral bleomycin for the treatment of recurrent glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Intratumoral doxorubicin in patients with malignant brain gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Treatment of refractory recurrent malignant glioma with adoptive cellular immunotherapy: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Local immunotherapy (beta-IFN) and systemic chemotherapy in primary glial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Chronic interstitial infusion of protein to primate brain: determination of drug distribution and clearance with single-photon emission computerized tomography imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Convection-enhanced delivery of macromolecules in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Convection-enhanced selective excitotoxic ablation of the neurons of the globus pallidus internus for treatment of parkinsonism in nonhuman primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Novel way to increase targeting specificity to a human glioblastoma-associated receptor for interleukin 13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Expression of a restrictive receptor for interleukin 13 is associated with glial transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

In vitro efficacy of transferrin-toxin conjugates against glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Polymers for the sustained release of proteins and other macromolecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Interstitial delivery of carboplatin via biodegradable polymers is effective against experimental glioma in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Drug targeting into the central nervous system by stereotactic implantation of biodegradable microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Biodegradable long-circulating polymeric nanospheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Stereotaxic implantation of 5-fluorouracil-releasing microspheres in malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

In vivo versus in vitro degradation of controlled release polymers for intracranial surgical therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Dose escalation of carmustine in surgically implanted polymers in patients with recurrent malignant glioma: a New Approaches to Brain Tumor Therapy CNS Consortium trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Phase II trial of docetaxel in patients with recurrent malignant glioma: a study of the National Cancer Institute of Canada Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Effect of stereotactic implantation of biodegradable 5-fluorouracil-loaded microspheres in healthy and C6 glioma-bearing rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Flexibility and efficacy of automatic continuous fluorodeoxyuridine infusion in metastases from a renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

The intraneoplastic chemotherapy in a rat brain tumour model utilizing methotrexate-polymethylmethacrylate-pellets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Interstitial chemotherapy of experimental gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Camptothecin analogs in malignant gliomas: comparative analysis and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Polymer delivery of camptothecin against 9L gliosarcoma: release, distribution, and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Local delivery of the topoisomerase I inhibitor camptothecin sodium prolongs survival in the rat intracranial 9L gliosarcoma model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

The role of minocycline in the treatment of intracranial 9L glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Local anti-angiogenic brain tumor therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Angiogenesis in malignant primary and metastatic brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Continuous low-dose chemotherapy plus inhibition of cyclooxygenase-2 as an antiangiogenic therapy of glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

Local delivery of antineoplastic agents by controlled-release polymers for the treatment of malignant brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

A controlled-release microchip

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400409

10.1177/153303460500400409

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

16029060